Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
BioArctic AB is a research-based biopharmaceutical company. It is primarily focused on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of revenue from Asia.
| Last: | $38.06 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $38.06 |
| Close: | $38.06 |
| High: | $38.06 |
| Low: | $38.06 |
| Volume: | 200 |
| Last Trade Date Time: | 02/25/2026 09:30:02 am |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about BioArctic (OTCMKTS: BRCTF).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
